Universal Health Services (UHS)
Market Price (4/15/2026): $181.99 | Market Cap: $11.3 BilSector: Health Care | Industry: Health Care Facilities
Universal Health Services (UHS)
Market Price (4/15/2026): $181.99Market Cap: $11.3 BilSector: Health CareIndustry: Health Care Facilities
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 14%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 9.7%, FCF Yield is 7.3% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11% Stock buyback supportStock Buyback 3Y Total is 2.2 Bil Low stock price volatilityVol 12M is 33% Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care, Diabetes Management, and Oncology Treatments. | Weak multi-year price returns2Y Excs Rtn is -27%, 3Y Excs Rtn is -26% | Key risksUHS key risks include [1] a significant dependence on revenue from government healthcare programs, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 14%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 9.7%, FCF Yield is 7.3% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11% |
| Stock buyback supportStock Buyback 3Y Total is 2.2 Bil |
| Low stock price volatilityVol 12M is 33% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease. Themes include Geriatric Care, Diabetes Management, and Oncology Treatments. |
| Weak multi-year price returns2Y Excs Rtn is -27%, 3Y Excs Rtn is -26% |
| Key risksUHS key risks include [1] a significant dependence on revenue from government healthcare programs, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Universal Health Services (UHS) stock has lost about 15% since 12/31/2025 because of the following key factors:
1. Universal Health Services (UHS) stock experienced a notable decline following its Q4 2025 earnings release on February 25, 2026, which included an earnings per share (EPS) miss and a perceived disappointing 2026 outlook.
The company reported an adjusted EPS of $5.88, falling short of analysts' consensus estimates of $5.91 by 0.51% (or $5.92 by $0.04). Additionally, net revenues of $4.49 billion were slightly below the anticipated $4.50 billion. This financial performance, coupled with a 2026 EPS guidance of $22.64 to $24.52, which was approximately 5% below previous estimates, led to a roughly 11% stock decline the day after the earnings announcement.
2. The company faced continued volume and margin pressures, exacerbated by elevated operating costs due to strategic investments in headcount and capacity.
In Q4 2025, same-facility adjusted admissions for acute care hospitals were flat, and adjusted patient days saw a 0.7% decrease compared to the prior year. Although behavioral health services showed modest growth in admissions (up 1.8%) and patient days (up 1.5%), UHS acknowledged falling short of its overall volume goals for 2025. Management indicated that operating costs were "elevated" due to investments in hiring and filling vacant positions to address staffing challenges and support future growth. These factors contributed to investor concerns about profitability and efficiency.
Show more
1. Universal Health Services (UHS) stock experienced a notable decline following its Q4 2025 earnings release on February 25, 2026, which included an earnings per share (EPS) miss and a perceived disappointing 2026 outlook.
The company reported an adjusted EPS of $5.88, falling short of analysts' consensus estimates of $5.91 by 0.51% (or $5.92 by $0.04). Additionally, net revenues of $4.49 billion were slightly below the anticipated $4.50 billion. This financial performance, coupled with a 2026 EPS guidance of $22.64 to $24.52, which was approximately 5% below previous estimates, led to a roughly 11% stock decline the day after the earnings announcement.
2. The company faced continued volume and margin pressures, exacerbated by elevated operating costs due to strategic investments in headcount and capacity.
In Q4 2025, same-facility adjusted admissions for acute care hospitals were flat, and adjusted patient days saw a 0.7% decrease compared to the prior year. Although behavioral health services showed modest growth in admissions (up 1.8%) and patient days (up 1.5%), UHS acknowledged falling short of its overall volume goals for 2025. Management indicated that operating costs were "elevated" due to investments in hiring and filling vacant positions to address staffing challenges and support future growth. These factors contributed to investor concerns about profitability and efficiency.
Show more
Stock Movement Drivers
Fundamental Drivers
The -16.5% change in UHS stock from 12/31/2025 to 4/14/2026 was primarily driven by a -24.0% change in the company's P/E Multiple.| (LTM values as of) | 12312025 | 4142026 | Change |
|---|---|---|---|
| Stock Price ($) | 217.81 | 181.95 | -16.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 16,993 | 17,365 | 2.2% |
| Net Income Margin (%) | 8.1% | 8.6% | 5.9% |
| P/E Multiple | 10.0 | 7.6 | -24.0% |
| Shares Outstanding (Mil) | 63 | 62 | 1.5% |
| Cumulative Contribution | -16.5% |
Market Drivers
12/31/2025 to 4/14/2026| Return | Correlation | |
|---|---|---|
| UHS | -16.5% | |
| Market (SPY) | -5.4% | 7.0% |
| Sector (XLV) | -3.9% | 16.3% |
Fundamental Drivers
The -10.8% change in UHS stock from 9/30/2025 to 4/14/2026 was primarily driven by a -27.2% change in the company's P/E Multiple.| (LTM values as of) | 9302025 | 4142026 | Change |
|---|---|---|---|
| Stock Price ($) | 204.07 | 181.95 | -10.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 16,460 | 17,365 | 5.5% |
| Net Income Margin (%) | 7.7% | 8.6% | 11.9% |
| P/E Multiple | 10.4 | 7.6 | -27.2% |
| Shares Outstanding (Mil) | 64 | 62 | 3.8% |
| Cumulative Contribution | -10.8% |
Market Drivers
9/30/2025 to 4/14/2026| Return | Correlation | |
|---|---|---|
| UHS | -10.8% | |
| Market (SPY) | -2.9% | 15.8% |
| Sector (XLV) | 7.4% | 22.0% |
Fundamental Drivers
The -2.8% change in UHS stock from 3/31/2025 to 4/14/2026 was primarily driven by a -29.5% change in the company's P/E Multiple.| (LTM values as of) | 3312025 | 4142026 | Change |
|---|---|---|---|
| Stock Price ($) | 187.16 | 181.95 | -2.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 15,828 | 17,365 | 9.7% |
| Net Income Margin (%) | 7.2% | 8.6% | 18.8% |
| P/E Multiple | 10.7 | 7.6 | -29.5% |
| Shares Outstanding (Mil) | 66 | 62 | 5.8% |
| Cumulative Contribution | -2.8% |
Market Drivers
3/31/2025 to 4/14/2026| Return | Correlation | |
|---|---|---|
| UHS | -2.8% | |
| Market (SPY) | 16.3% | 37.7% |
| Sector (XLV) | 3.3% | 37.8% |
Fundamental Drivers
The 45.1% change in UHS stock from 3/31/2023 to 4/14/2026 was primarily driven by a 70.0% change in the company's Net Income Margin (%).| (LTM values as of) | 3312023 | 4142026 | Change |
|---|---|---|---|
| Stock Price ($) | 125.37 | 181.95 | 45.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 13,399 | 17,365 | 29.6% |
| Net Income Margin (%) | 5.0% | 8.6% | 70.0% |
| P/E Multiple | 13.2 | 7.6 | -42.6% |
| Shares Outstanding (Mil) | 71 | 62 | 14.7% |
| Cumulative Contribution | 45.1% |
Market Drivers
3/31/2023 to 4/14/2026| Return | Correlation | |
|---|---|---|
| UHS | 45.1% | |
| Market (SPY) | 63.3% | 33.1% |
| Sector (XLV) | 20.4% | 38.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| UHS Return | -5% | 9% | 9% | 18% | 22% | -17% | 35% |
| Peers Return | 54% | -18% | 6% | 15% | 7% | 20% | 96% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -0% | 81% |
Monthly Win Rates [3] | |||||||
| UHS Win Rate | 50% | 67% | 50% | 58% | 58% | 50% | |
| Peers Win Rate | 65% | 43% | 50% | 52% | 53% | 65% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| UHS Max Drawdown | -15% | -32% | -17% | -0% | -13% | -19% | |
| Peers Max Drawdown | -3% | -43% | -18% | -14% | -27% | -7% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -7% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: HCA, THC, CYH, ACHC, SEM. See UHS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/14/2026 (YTD)
How Low Can It Go
| Event | UHS | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -45.3% | -25.4% |
| % Gain to Breakeven | 82.9% | 34.1% |
| Time to Breakeven | 492 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -54.2% | -33.9% |
| % Gain to Breakeven | 118.3% | 51.3% |
| Time to Breakeven | 399 days | 148 days |
| 2018 Correction | ||
| % Loss | -24.4% | -19.8% |
| % Gain to Breakeven | 32.2% | 24.7% |
| Time to Breakeven | 113 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -52.7% | -56.8% |
| % Gain to Breakeven | 111.4% | 131.3% |
| Time to Breakeven | 214 days | 1,480 days |
Compare to HCA, THC, CYH, ACHC, SEM
In The Past
Universal Health Services's stock fell -45.3% during the 2022 Inflation Shock from a high on 8/3/2021. A -45.3% loss requires a 82.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Universal Health Services (UHS)
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
AI Analysis | Feedback
Marriott for hospitals and behavioral health centers.
AI Analysis | Feedback
- Acute Care Hospital Services: Provides a broad spectrum of medical and surgical treatments within hospital settings.
- Behavioral Health Care Services: Offers mental health and substance abuse treatment through inpatient and outpatient facilities.
- Commercial Health Insurance Services: Sells health insurance plans to commercial customers.
- Management and Administrative Services: Provides centralized support functions such as purchasing, IT, finance, facility planning, and human resources for its healthcare operations.
AI Analysis | Feedback
Universal Health Services (UHS) primarily serves individuals directly through its healthcare facilities and, in some cases, through its commercial health insurance services. As such, its major customers can be categorized as follows:
- Patients Requiring Acute Medical Care: This category includes individuals seeking a wide range of medical services offered by UHS's acute care hospitals, such as general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, and pediatric services.
- Patients Requiring Behavioral Health Services: This category encompasses individuals seeking mental health and substance abuse treatment services provided by UHS's extensive network of behavioral health care facilities.
- Individuals Enrolled in Commercial Health Insurance Plans: UHS also provides commercial health insurance services. Therefore, individuals who purchase or are covered by these health insurance plans are direct customers for that specific service offering.
AI Analysis | Feedback
nullAI Analysis | Feedback
Marc D. Miller, President and Chief Executive Officer
Marc D. Miller was named CEO of Universal Health Services in January 2021, having served as President since 2009. He began his career at UHS in 1995, holding various positions of increasing responsibility at both hospitals and the corporate office. His prior operating roles included CEO/Managing Director of Central Montgomery Medical Center and Chief Operating Officer of Wellington Regional Medical Center. He also served as Group Director for Acute Care operations, Eastern Region Vice President of the Acute Care Division, Senior Vice President and Co-head of the UHS Acute Care Division, and President of the Acute Care Division. Mr. Miller holds an MBA in Healthcare from The Wharton School of the University of Pennsylvania.
Steve G. Filton, Executive Vice President and Chief Financial Officer
Steve G. Filton joined Universal Health Services in 1985 as Director of Corporate Accounting after six years in the audit division of Arthur Andersen. He assumed the role of Chief Financial Officer effective July 1, 2003, having previously served as UHS Vice President, Controller, and Secretary. Mr. Filton is a Certified Public Accountant and holds a Bachelor of Science degree in accounting from the Wharton School of the University of Pennsylvania.
Alan B. Miller, Founder and Executive Chairman of the Board
Alan B. Miller founded Universal Health Services, Inc. in 1979. Prior to establishing UHS, he served as Chairman and CEO of American Medicorp Inc., a pioneering hospital management company. He stepped down as CEO of UHS in January 2021, transitioning the role to Marc D. Miller, and continues to serve as Executive Chairman of the Board. Mr. Miller also founded Universal Health Realty Income Trust (UHT) in 1986, where he continues to serve as Chairman of the Board, President, and Chief Executive Officer.
Edward H. Sim, Executive Vice President and President, Acute Care Division
Matthew D. Klein, Senior Vice President and General Counsel
AI Analysis | Feedback
Universal Health Services (UHS) faces several key risks that could impact its business operations and financial performance. These risks primarily stem from the evolving healthcare landscape, operational challenges, and potential legal issues.
- Policy Headwinds and Regulatory Shifts: UHS is significantly exposed to changes in government healthcare policies and reimbursement models. The expiration of enhanced subsidies for Affordable Care Act (ACA) plans is projected to result in a $75 million pretax headwind for the company, as it may lead to higher premiums and a potential loss of insurance coverage for millions of Americans. Furthermore, there is a broader industry shift towards value-based care and site-neutral payments, driven by the Centers for Medicare & Medicaid Services (CMS)'s 2026 Physician Fee Schedule Final Rule, which accelerates the transition to two-sided financial risk. UHS's reliance on Medicaid supplemental payments also poses a risk, with federal and state proposed changes potentially reducing these payments by $300-400 million annually, impacting profits. Policy uncertainty around government reimbursement is identified as a significant near-term structural risk.
- Labor Shortages and Rising Costs: The healthcare industry, including UHS, is grappling with persistent labor shortages and escalating operational costs. These shortages have particularly affected UHS's behavioral health unit, leading to struggles in meeting patient day growth targets. The company anticipates a $35 million impact in its behavioral unit due to higher labor costs for recruiting and training staff, with ongoing annual costs projected at $30 million beyond 2026 due to new California staffing mandates. This trend of rising costs contributes to a shrinking adjusted operating margin and free cash flow margin, indicating challenges in passing these increased expenses on to customers.
- Legal and Reputational Risks: Universal Health Services faces significant legal and reputational risks due to numerous lawsuits, particularly those alleging sexual abuse at its facilities. These allegations, especially concerning its psychiatric centers, have led to investigations into the potential failings of UHS's leadership for breaches of fiduciary duties. Such legal challenges and investigations amplify pressure on the company, potentially swaying public sentiment, impacting investor confidence, and casting a shadow over its leadership and ethical practices.
AI Analysis | Feedback
Emergence of hospital-at-home models: These programs provide acute-level care to patients in their own homes, leveraging remote monitoring, telemedicine, and in-person visits from healthcare professionals. This directly challenges the traditional inpatient hospital model for certain conditions, potentially diverting admissions and reducing demand for acute care beds, a core service of Universal Health Services.
Proliferation of digital mental health platforms and virtual-first behavioral health providers: These platforms offer a wide range of services, including virtual therapy, psychiatry, and digital therapeutics, often through subscription models or direct employer partnerships. This could significantly impact demand for Universal Health Services' traditional brick-and-mortar outpatient and potentially even some inpatient behavioral health services by offering more accessible, convenient, and often lower-cost alternatives.
AI Analysis | Feedback
Universal Health Services (UHS) operates primarily in two main segments: Acute Care Hospital Services and Behavioral Health Care Services. The addressable markets for these services are substantial in the regions where the company operates.
Acute Care Hospital Services
- In the U.S., the acute hospital care market was valued at approximately USD 1.35 trillion in 2025 and is projected to grow to about USD 2.43 trillion by 2034. Another estimate valued the market at USD 1,480.9 billion in 2021, with a projection to reach USD 2,635.6 billion by 2030.
- In the United Kingdom, the total private acute healthcare market was valued at £13.8 billion (approximately USD 17.5 billion) in 2024. Independent acute hospitals, a key part of this market, accounted for £7.2 billion of this value in 2024. The broader UK private healthcare market, which includes acute services, was valued at approximately USD 13.75 billion in 2024 and is projected to surpass USD 18.56 billion by 2033.
Behavioral Health Care Services
- In the U.S., the behavioral health market was valued at USD 94.82 billion in 2025 and is anticipated to reach around USD 174.78 billion by 2035. Other projections estimate the U.S. market at USD 87.82 billion in 2024, growing to USD 132.46 billion by 2032.
- Globally, the behavioral health market was valued at USD 184.94 billion in 2025 and is projected to reach approximately USD 349.88 billion by 2035. North America contributed the largest market share of 63.7% in 2025 to the global behavioral health market.
AI Analysis | Feedback
Universal Health Services (UHS) is expected to drive future revenue growth over the next 2-3 years through several key initiatives and market trends:- Increased Patient Volumes and Demand: UHS anticipates continued strong demand and volume growth in both its Acute Care and Behavioral Health segments. For instance, same-facility volume growth is projected to be in the range of 2% to 3% for both segments for the full year 2026. Acute care hospitals have demonstrated consistent increases in adjusted admissions, such as a 4.5% year-over-year rise in Q1 2024. The behavioral health segment is also expected to see improved patient day growth, with investments in staffing capacity intended to support higher volumes.
- Strategic Expansion of Facilities and Services: The company is actively expanding its physical footprint and service offerings. This includes opening new acute care hospitals, such as West Henderson Hospital in Las Vegas in late 2024 and Cedar Hill Medical Center in Washington D.C. in the coming months. UHS also plans for inpatient expansions in various states like Florida, California, and Nevada, alongside the opening of new behavioral health facilities and a state-of-the-art de novo hospital in Palm Beach Gardens, Florida. Furthermore, the company is growing its outpatient behavioral health network, with plans to open at least 10 new "1,000 branches Wellness brand" locations in 2026.
- Pricing Gains and Enhanced Revenue per Patient: UHS expects to benefit from solid pricing across both its acute care and behavioral health segments. There have been consistent increases in net revenue per adjusted admission for acute care (e.g., 4.6% in Q1 2024) and net revenue per adjusted patient day for behavioral health (e.g., 8.2% in Q1 2024). A favorable payer mix, with a shift towards less Medicaid and more Commercial and Exchange volume, is also contributing to advantageous pricing in the acute care segment and is expected to continue.
- Medicaid Supplemental Reimbursement Programs: Incremental income from state-specific Medicaid supplemental reimbursement programs is a recurring driver. Examples include approximately $18 million from the Mississippi Hospital Access Program in Q4 2023 and around $38 million from a newly implemented program in Nevada in Q1 2024. The company recorded an aggregate of approximately $50 million in similar reimbursements during Q4 2024.
- Expansion into Virtual Services and Integrated Care Models: The strategic acquisition of Talkspace is a pivotal move that positions UHS to expand into a comprehensive, hybrid care model leveraging virtual services. This acquisition is expected to address behavioral health staffing bottlenecks and diversify the company's payer mix, contributing to long-term growth.
AI Analysis | Feedback
Share Repurchases
- Universal Health Services has consistently engaged in significant share repurchases, with $599 million in shares repurchased during 2024.
- In the first quarter of 2025, the company acquired 1 million shares for approximately $181 million, and in the second quarter of 2025, repurchased 875,000 shares for approximately $150.8 million.
- Since 2019, UHS has repurchased approximately 31% of its outstanding shares, contributing to a steady decline in shares outstanding over the last several years, including a 5.06% decline in 2025 from 2024.
Outbound Investments
- In March 2026, Universal Health Services announced a definitive agreement to acquire virtual behavioral health provider Talkspace for approximately $835 million in an all-cash transaction.
- This acquisition is strategically aimed at integrating Talkspace's nationwide digital behavioral health platform with UHS's extensive network to address staffing bottlenecks and expand into a hybrid care model.
Capital Expenditures
- Universal Health Services consistently invests significantly in capital expenditures, with $944 million spent in 2024 and $743 million in 2023.
- Projected capital expenditures are between $850 million and $1 billion for 2025, and $950 million to $1.1 billion for 2026.
- The primary focus of these expenditures includes expanding capacity and improving efficiency through new facilities (e.g., West Henderson Hospital in late 2024, a new acute care hospital in Washington D.C. in April 2025), adding behavioral health beds, and investing in advanced technology, including AI tools.
Latest Trefis Analyses
Trade Ideas
Select ideas related to UHS.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 03312026 | PGNY | Progyny | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 03272026 | CNC | Centene | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 2.3% | 2.3% | -0.6% |
| 03272026 | OSCR | Oscar Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.0% | 3.0% | -2.6% |
| 03202026 | WAT | Waters | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | -0.4% | -0.4% | -3.3% |
| 03202026 | GILD | Gilead Sciences | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 1.6% | 1.6% | -2.2% |
| 06302022 | UHS | Universal Health Services | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 40.3% | 57.7% | -12.6% |
| 09302020 | UHS | Universal Health Services | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 24.8% | 29.8% | -1.5% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 104.25 |
| Mkt Cap | 6.8 |
| Rev LTM | 14,925 |
| Op Inc LTM | 1,539 |
| FCF LTM | 516 |
| FCF 3Y Avg | 540 |
| CFO LTM | 1,204 |
| CFO 3Y Avg | 1,108 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 5.1% |
| Rev Chg 3Y Avg | 6.8% |
| Rev Chg Q | 6.6% |
| QoQ Delta Rev Chg LTM | 1.6% |
| Op Mgn LTM | 11.6% |
| Op Mgn 3Y Avg | 12.1% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 8.5% |
| CFO/Rev 3Y Avg | 10.2% |
| FCF/Rev LTM | 3.4% |
| FCF/Rev 3Y Avg | 5.1% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 6.8 |
| P/S | 0.7 |
| P/EBIT | 4.9 |
| P/E | 9.9 |
| P/CFO | 5.9 |
| Total Yield | 8.6% |
| Dividend Yield | 0.2% |
| FCF Yield 3Y Avg | 7.0% |
| D/E | 0.9 |
| Net D/E | 0.8 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -4.8% |
| 3M Rtn | 1.4% |
| 6M Rtn | 5.0% |
| 12M Rtn | 10.6% |
| 3Y Rtn | 23.3% |
| 1M Excs Rtn | -9.8% |
| 3M Excs Rtn | 2.0% |
| 6M Excs Rtn | 1.3% |
| 12M Excs Rtn | -20.3% |
| 3Y Excs Rtn | -39.9% |
Comparison Analyses
Price Behavior
Price Behavior
| Market Price | $181.95 | |
| Market Cap ($ Bil) | 11.3 | |
| First Trading Date | 03/26/1990 | |
| Distance from 52W High | -25.4% | |
| 50 Days | 200 Days | |
| DMA Price | $200.68 | $200.65 |
| DMA Trend | indeterminate | down |
| Distance from DMA | -9.3% | -9.3% |
| 3M | 1YR | |
| Volatility | 38.1% | 33.2% |
| Downside Capture | 0.32 | 0.31 |
| Upside Capture | 18.84 | 47.12 |
| Correlation (SPY) | 6.5% | 31.1% |
UHS Betas & Captures as of 3/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.26 | 0.07 | 0.25 | 0.41 | 0.69 | 0.66 |
| Up Beta | 0.21 | 0.48 | 0.45 | 0.14 | 0.75 | 0.72 |
| Down Beta | -0.39 | -0.12 | -0.39 | 0.13 | 0.81 | 0.54 |
| Up Capture | 2% | -12% | 10% | 48% | 36% | 41% |
| Bmk +ve Days | 7 | 16 | 27 | 65 | 139 | 424 |
| Stock +ve Days | 6 | 20 | 28 | 62 | 133 | 404 |
| Down Capture | 101% | 38% | 99% | 74% | 67% | 86% |
| Bmk -ve Days | 12 | 23 | 33 | 58 | 110 | 323 |
| Stock -ve Days | 16 | 22 | 35 | 64 | 119 | 347 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with UHS | |
|---|---|---|---|---|
| UHS | 2.5% | 33.2% | 0.11 | - |
| Sector ETF (XLV) | 11.9% | 16.0% | 0.52 | 30.1% |
| Equity (SPY) | 24.2% | 12.9% | 1.49 | 30.6% |
| Gold (GLD) | 53.4% | 27.6% | 1.55 | -5.6% |
| Commodities (DBC) | 26.8% | 16.2% | 1.47 | -0.9% |
| Real Estate (VNQ) | 18.7% | 13.8% | 1.00 | 24.6% |
| Bitcoin (BTCUSD) | -6.8% | 42.9% | -0.05 | -7.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with UHS | |
|---|---|---|---|---|
| UHS | 6.5% | 31.3% | 0.25 | - |
| Sector ETF (XLV) | 6.6% | 14.6% | 0.27 | 45.6% |
| Equity (SPY) | 11.1% | 17.0% | 0.50 | 43.7% |
| Gold (GLD) | 22.5% | 17.8% | 1.03 | 6.9% |
| Commodities (DBC) | 11.7% | 18.8% | 0.51 | 10.6% |
| Real Estate (VNQ) | 3.9% | 18.8% | 0.11 | 44.5% |
| Bitcoin (BTCUSD) | 5.8% | 56.5% | 0.32 | 10.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with UHS | |
|---|---|---|---|---|
| UHS | 4.5% | 34.1% | 0.22 | - |
| Sector ETF (XLV) | 9.9% | 16.5% | 0.49 | 50.7% |
| Equity (SPY) | 14.0% | 17.9% | 0.67 | 51.7% |
| Gold (GLD) | 14.3% | 15.9% | 0.75 | 2.1% |
| Commodities (DBC) | 8.8% | 17.6% | 0.42 | 22.2% |
| Real Estate (VNQ) | 5.4% | 20.7% | 0.23 | 52.5% |
| Bitcoin (BTCUSD) | 67.7% | 66.9% | 1.07 | 12.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/26/2026 | -11.4% | -12.2% | -19.7% |
| 10/28/2025 | 2.5% | 3.1% | 13.9% |
| 7/29/2025 | 5.1% | 6.3% | 17.1% |
| 2/27/2025 | 3.3% | -1.2% | 3.7% |
| 10/25/2024 | -9.8% | -9.1% | -11.9% |
| 7/25/2024 | 10.2% | 14.9% | 23.3% |
| 2/27/2024 | -2.4% | 6.0% | 9.8% |
| 10/26/2023 | 1.7% | 2.6% | 13.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 10 | 12 |
| # Negative | 9 | 8 | 6 |
| Median Positive | 3.9% | 6.1% | 11.7% |
| Median Negative | -5.6% | -6.7% | -12.3% |
| Max Positive | 13.1% | 21.3% | 34.1% |
| Max Negative | -11.4% | -13.6% | -19.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/25/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/08/2025 | 10-Q |
| 03/31/2025 | 05/08/2025 | 10-Q |
| 12/31/2024 | 02/26/2025 | 10-K |
| 09/30/2024 | 11/08/2024 | 10-Q |
| 06/30/2024 | 08/08/2024 | 10-Q |
| 03/31/2024 | 05/08/2024 | 10-Q |
| 12/31/2023 | 02/27/2024 | 10-K |
| 09/30/2023 | 11/08/2023 | 10-Q |
| 06/30/2023 | 08/08/2023 | 10-Q |
| 03/31/2023 | 05/08/2023 | 10-Q |
| 12/31/2022 | 02/27/2023 | 10-K |
| 09/30/2022 | 11/08/2022 | 10-Q |
| 06/30/2022 | 08/08/2022 | 10-Q |
| 03/31/2022 | 05/06/2022 | 10-Q |
Recent Forward Guidance [BETA]
Latest: Q4 2025 Earnings Reported 2/26/2026
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2026 Net revenues | 18.42 Bil | 18.60 Bil | 18.79 Bil | 7.1% | Higher New | Actual: 17.38 Bil for 2025 | |
| 2026 Adjusted EBITDA net of NCI | 2.64 Bil | 2.71 Bil | 2.79 Bil | 4.7% | Higher New | Actual: 2.59 Bil for 2025 | |
| 2026 EPS-diluted | 22.6 | 23.6 | 24.5 | 8.2% | Higher New | Actual: 21.8 for 2025 | |
| 2026 Capital expenditures | 950.00 Mil | 1.02 Bil | 1.10 Bil | ||||
Prior: Q3 2025 Earnings Reported 10/28/2025
| Forward Guidance | Guidance Change | ||||||
|---|---|---|---|---|---|---|---|
| Metric | Low | Mid | High | % Chg | % Delta | Change | Prior |
| 2025 Net revenues | 17.31 Bil | 17.38 Bil | 17.45 Bil | 1.0% | Raised | Guidance: 17.20 Bil for 2025 | |
| 2025 Adjusted EBITDA, net of NCI | 2.57 Bil | 2.59 Bil | 2.62 Bil | 3.7% | Raised | Guidance: 2.50 Bil for 2025 | |
| 2025 Adjusted EPS – diluted | 21.5 | 21.8 | 22.1 | 6.3% | Raised | Guidance: 20.5 for 2025 | |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nimetz, Warren J | Direct | Sell | 11122025 | 223.30 | 3,817 | 852,343 | 1,893,823 | Form | |
| 2 | Sussman, Elliot J Md Mba | Direct | Sell | 10302025 | 225.70 | 965 | 217,799 | 1,379,692 | Form | |
| 3 | Singer, Maria Ruderman | Direct | Sell | 5152025 | 191.48 | 1,097 | 210,053 | 1,509,626 | Form | |
| 4 | Singer, Maria Ruderman | Direct | Sell | 3112025 | 179.16 | 1,000 | 179,161 | 1,418,237 | Form | |
| 5 | Sussman, Elliot J Md Mba | Direct | Sell | 3132026 | 186.35 | 318 | 59,258 | 1,139,130 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.